NCT01432249View on ClinicalTrials.gov

Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Pediatric Psoriasis
Interventions
DRUG

Enbrel group

will be decided by treating physicians

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY